






Toxoplasmosis and Cerebral Toxoplasmosis in HIV/AIDS Patients in Kariadi 
Hospital, Semarang 
 
Dauda Sanni Hassana*, Suharyo Hadisaputro**, Muchlis Achsan Udji Sofro***  
*Master of Epidemiology, School of Postgraduate, University of Diponegoro, Semarang, Indonesia. 
**Faculty of Medicine, , University of Diponegoro, Semarang, Indonesia. 
***Kariadi Hospital, Semarang, Indonesia. 
 
ABSTRACT 
Background: Toxoplasmosis is an infection caused by Toxoplasma gondii, which affects the 
central nervous system resulting to a fatal situation in HIV patients, especially at the advanced 
stage. Cerebral toxoplasmosis (CT) is the clinical presentation of toxoplasmosis in individuals with 
HIV/AIDS. The study was carried out to describe the prevalence of toxoplasmosis and cerebral 
toxoplasmosis in HIV/AIDS patients attending the hospital setting used in the study. 
Methods: Patients medical records were checked and analyzed for demographic characteristics as 
well as to determine the results of toxoplasma IgG tests for HIV/AIDS patients as well as those who 
had cerebral toxoplasmosis. The study was descriptive. 
Result: Out of the 158 HIV/AIDS patients tested, 129 (81.6%) were positive for T. gondii. A 
62.0% prevalence rate was recorded for the male subjects while 19.6% prevalence rate was 
recorded for the female subjects although there was no significant difference (X2=0.58, P > 0.05). 
69.3% of the total population studied had cerebral toxoplasmosis with a prevalence rate of 74.3% 
and 25.3%) in male and female respectively. A higher prevalence was recorded from the age group 
>30years without significant difference (X2=0.74, P > 0.05). 
Conclusion: More research is required to know the exact prevalence of the parasite in this group of 
individuals since not all the patients were tested. 
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 Toxoplasmosis is caused by an infection 
with the coccidian Toxoplasma gondii, and it is 
considered as a significant public health 
problem worldwide, causing a chronic 
condition where most of the cases are 
asymptomatic and remains undetected.1 It 
infects approximately one-third of the world’s 
population2 with these infections having a 
significant consequence affecting mortality and 
quality of life. It frequently affects the central 
nervous system resulting to a fatal situation in 
HIV patients, especially at the advanced 
stage3,4. However, the incidence of this disease 
has decreased due to the introduction of 
antiretroviral treatment (ART).5 Cerebral 
toxoplasmosis (CT) is the clinical presentation 
of toxoplasmosis in individuals with 
HIV/AIDS, and it has been proven in 35% of 
HIV/AIDS patients to be an HIV-indicative 
disease while also proven in 75% of such cases 
to be an AIDS-defining disease.6 The 
reactivation of the parasite thereby bringing 
about cerebral toxoplasmosis is through a 
mechanism where some vital cells such as CD4 
cells are depleted as well as decreased 
production of others.7 
  Prevalence rate of Toxoplasma infection 
among HIV positive individuals worldwide, 
varies from 3% to 97%.8 In Southeast Asia, the 
seroprevalence of toxoplasmosis was recorded 
to be low in countries which a climate 
described as tropical monsoon, e.g. Cambodia, 
Thailand, Vietnam, Laos etc. but 59.7% of 
inhabitants in Malaysia were T. gondii 
seropositive.9  The seroprevalence of 
toxoplasmosis in Indonesia also appears to vary 
in different regions, e.g. in Surabaya, the 
prevalence was found to be 63%, in Jakarta, it 
was 75%, in Yogyakarta it was 61.5%, and in 
Central Java, it was 62.54%.10,11 There is a 
paucity of knowledge about infection due to 
Toxoplasma gondii among individuals positive 
for HIV in RSUP Dr. Kariadi Semarang, which 
is one of the leading hospitals in the region 
having a high prevalence of HIV/AIDS 
patients. Herein, we describe the prevalence of 
toxoplasmosis and cerebral toxoplasmosis in 
HIV/AIDS patients who attended this hospital 
setting within the periods of 2015 – 2019.  
Methods 
Study Population  
All HIV/AIDS patients aged 18 years and 
above who received medical care, between 
2015 and 2019 at RSUP Dr. Kariadi Hospital 
Semarang were the subjects for this study. This 
hospital was chosen because it is one of the 
leading hospitals in Indonesia, which provides 
care and services to HIV/AIDS patients. 101 
HIV-positive patients were diagnosed with 
cerebral toxoplasmosis during the study period, 
seen from a lesion having a mass effect on 
cerebral tomography imaging and a serum 
antibody to T. gondii while 57 patients were 
HIV positive but with no cerebral 
toxoplasmosis, giving a total of 158 subjects 
used in the study. 
 
Study design and Data Collection  
This study was a descriptive clinical study, 
based on retrospectively collected information 
and a standardization and clinical validation of 
a laboratory assay. The study was approved by 
the research and ethics committee of RSUP Dr. 
Kariadi hospital Semarang, Central Java 
province in Indonesia. Written informed 
consent was also obtained from the hospital to 
access the medical records of the patients since 
the researcher did not meet with the patients. 
Demographic characteristics, clinical and 
laboratory data were all collected from the 
medical records for the specific purpose of the 
study at the RSUP Dr. Kariadi hospital, 
between November 2019 and January 2020.   
 
Statistical Analyses  
Data collected and used in this study were 
all checked for accuracy, completeness and 
consistency. A computer program SPSS 
(Statistical Package for Social Sciences, 
version 22.0) for Windows was used to analyze 
the data collected. In other to compare 
Toxoplasma gondii infection among the 
variables, the Chi-square test was used. This 
test is useful in testing the relationship or effect 
of two variables as well as in measuring the 
strength of the relationship between two 
variables. The p < 0.05, i.e. 5% level of 
significance was used in the study. 
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 HIV/AIDS patients who attended RSUP Dr. 
Kariadi hospital from 2015-2019 who were 
tested for anti-toxoplasma antibodies was 
searched for in the hospital medical records, 
and the results were carefully analyzed. A total 
of 158 adult patients’ record was used in this 
study, with their ages ranging from 18 to 63. 
The CD4 counts of all patients were also 
recorded with most of the patients having CD4 
counts less than 50cell/ul (66.46%) while those 
with CD4 counts higher than 100 were just 
12.6% with the others having counts between 
fifty and hundred cells/microliter. Of the 158 
HIV/AIDS patients tested, 129 (81.6%) were 
positive for T. gondii (Table 2). Gender wise, 
the prevalence rates were 98 (62.0%) for the 
male subjects, and the prevalence rate for the 
females was 31(19.6). The prevalence for T. 
gondii did not differ significantly between 
sexes. 
Table 1. Age and gender data for the subjects 
Table 2. Prevalence of T. gondii in HIV/AIDS 





         No                  % 
Male 118 98               76.0 
Female 40 31               24.6 
Total 158        129               100 
X2=0.58 (P > 0.05) 
Since IgG positivity and subsequent 
reactivation of the parasite leads to cerebral 
toxoplasmosis in these patients, the prevalence 
of cerebral toxoplasmosis was further 
examined. Of the 158 patients tested, only 101 
(63.9%) were positive for cerebral 
toxoplasmosis. The prevalence rate in men was 
75 (74.3%) while in ladies, it was 26 (25.3%) 
(Table 3). Age-wise, the patients were divided 
into two groups (<30 and >30 years) and a 
higher prevalence rate of 72.3% was gotten 
from the age group greater than 30years (Table 
4) although it was not statistically associated 
with cerebral toxoplasmosis. 
Table 3. Prevalence of Cerebral Toxoplasmosis 






  No               % 
Male 118 75               74.3 
Female 40 26                25.7 
Total 158 101               100 
Table 4. Prevalence of Cerebral Toxoplasmosis 
in HIV/AIDS patients in relation to age group 
Age No tested Cerebral 
Toxoplasmosis 
positivity 
       No                  % 
<30 46 28               27.7 
>30 112 73               72.3 
Total 158       101               100 
X2=0.74 (P > 0.05) 
  
Discussion 
1,160 new HIV infected patients visited 
the hospital during the study period of which 
only 158 patients were tested for anti-
toxoplasma antibodies this is because, in this 
health care setting, only patients who present 
signs and symptoms for toxoplasma infection 
Age 
(years) 
Number of Individuals Total 
      Male           Female         
   
 
18 to 29       30              15 45 
30 to 39       36              15 51 
40 to 49       36                7 43 
>=50        16                3 19 
Total      188            40 158 
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were tested. The seroprevalence of Toxoplasma 
IgG antibodies in HIV/aids patients in RSUP 
Dr. Kariadi was found to be 81.6% while those 
who had the reactivation of this parasite, 
thereby resulting to cerebral toxoplasmosis was 
63.9%. The prevalence of T. gondii gotten in 
this research was lower than reports observed 
by Yulia et al. .12 and Amuta et al.13 where they 
reported a seroprevalence of 35.2% 10.8% in 
VCT clinic at the Dr Moewardi General 
Hospital in Surakarta, Indonesia and Makurdi 
Nigeria respectively.   
This high prevalence could be due to the 
fact that RSUP Dr. Kariadi is the biggest 
hospital caring for individuals with HIV/AIDS 
in the region, and as such, most of the patients 
are found here. It could also be due to the 
limited number of the sample used in the study. 
Other studies from other Asian countries have 
also reported high seroprevalence of T. gondii 
in HIV patients although the result from the 
present study is still higher than that reported 
by Nissapatorn et al. (51.2%)14 and Minoo et 
al. (49.7%)15 in Kuala Lumpur and Iran 
respectively. Gender wise, the prevalence was 
higher (62.0%) in males than in females 
(19.6%). This could be due to the fact that men 
may be more actively involved in risk activities 
which expose them to this parasite, although 
the result was not statistically significant. 
Therefore, the result is in line with the result 
obtained by of Nissapatorn et al14 were a 
significantly higher positive rate was reported 
in men (48.0%) as compared to females (9.3%) 
in HIV infected patients at Hospital Kuala 
Lumpur, Malaysia, but the result disagrees with 
result obtained from Yulia et al12 where a no 
significant difference was reported between 
males and females. 
 The prevalence rate of cerebral 
toxoplasmosis in men was also higher (74.3%) 
than in ladies (25.3%). This could be due to the 
fact that ladies tend to report early enough to 
hospitals for treatment than their male 
counterparts who wait until the sickness 
deteriorates. A higher prevalence rate of 72.3% 
was also observed from the age group greater 
than 30years although it was not statistically 
associated with cerebral toxoplasmosis. This 
indicates that the patients who fall in this age 
group are likely to be more predisposed to 
cerebral toxoplasmosis infection than the other 
age group which could be as a result of low 
CD4 counts, non-compliance to taking ARV 
and maybe consumption of raw or undercooked 
meats and vegetables like satay which is a 
common type of meat consumed here in 
Indonesia. 
      The small number of the sample used is 
also another limitation, and this was as a result 
of the fact that most HIV infected patients in 
this setting are not tested for toxoplasma IgG. 
Conclusion 
 
In conclusion, testing for antibodies against T. 
gondii is highly suggested in HIV/AIDS 
patients in other to reduce the amount of 
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